Early Access — free while we kick the tires
EdgarHawk

PROEHL GERALD T

Director

Director
1 filing analyzed · 1 company · Latest 2024-08-08

Companies

Company Buys Sells Direction
TENAX THERAPEUTICS, INC. TENX 1 0 Net buying

Activity

August 2024
medium
Buy
1,666 shares
Significance 4/10

Director PROEHL bought 1,666 shares of TENX on 2024-08-08; holdings rose from 1 to 1,667 shares (+166600.0%)

PROEHL GERALD T, a director, acquired 1,666 shares on 2024-08-08, increasing his holdings from 1 share to 1,667 shares. The transaction value is recorded as $0.00, indicating either a non-cash acquisition (e.g., restricted stock grant, warrant exercise, or stock dividend) or a data-reporting anomaly. The company presents concerning fundamentals: Revenue is $0.00 for the latest quarter with -100.0% annual revenue growth, net income sits at $3,798,840.00 ($3.8M) against a $8.1M market cap, and the P/E is 0.80, signaling a company in severe contraction. The stock has declined 91.6% from its 52-week high of $49.60 to the current price of $4.14, though it has recovered 29.8% over the past 30 days. Without clarity on the transaction mechanism (price, cash vs. non-cash consideration), investors cannot determine whether this represents a deliberate capital commitment or a routine corporate action such as vesting or dividend reinvestment.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access